Umcka Allergy And Sinus Tablet, Chewable
NDC Package 53499-3194-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Umcka Allergy And Sinus (pelargonium sidoides root, hydrastis canadensis whole, potassium chloride, sanguinaria canadensis root, pulsatilla vulgaris, silicon dioxide) tablets is shortens duration and reduces severity of symptoms associated with the common cold and throat, nasal, bronchial irritations and temporarily relieves allergy and sinus symptoms; cough, congestion, promotes sinus drainage, helps decongest sinus openings and passages, headache, sneezing/runny nose, burning, itchy eyes, sore throat, shrinks swollen nasal membranes, sinus presssure. This formulation utilizes a tablet, chewable delivery system. Marketed by Schwabe North American, Inc., this product is identified by NDC 53499-3194.

Identification & Billing

NDC Package Code
53499-3194-2
Package Description
2 BLISTER PACK in 1 CARTON / 10 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
53499319402

Clinical Specifications

Proprietary Name
Umcka Allergy And Sinus
Non-Proprietary Name
Pelargonium Sidoides Root, Hydrastis Canadensis Whole, Potassium Chloride, Sanguinaria Canadensis Root, Pulsatilla Vulgaris, Silicon Dioxide
Substance Name
Hydrastis Canadensis Whole; Pelargonium Sidoides Root; Potassium Chloride; Pulsatilla Vulgaris; Sanguinaria Canadensis Root; Silicon Dioxide
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Shortens duration and reduces severity of symptoms associated with the common cold and throat, nasal, bronchial irritations and temporarily relieves allergy and sinus symptoms; cough, congestion, promotes sinus drainage, helps decongest sinus openings and passages, headache, sneezing/runny nose, burning, itchy eyes, sore throat, shrinks swollen nasal membranes, sinus presssure.

Regulatory & Marketing

Labeler Name
Schwabe North American, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
06-01-2018
End Marketing Date
06-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53499-3194-2 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet, chewable in 1 blister pack of Umcka Allergy And Sinus, a human over the counter drug labeled by Schwabe North American, Inc.. This tablet, chewable is formulated for oral use and contains hydrastis canadensis whole; pelargonium sidoides root; potassium chloride; pulsatilla vulgaris; sanguinaria canadensis root; silicon dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Schwabe North American, Inc. on June 01, 2018.

How is this Schwabe North American, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53499319402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53499-3194-2
11-Digit CMS (5-4-2)
53499-3194-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.